MedTrace Logo

Effect of Digital Storytelling Intervention on Diabetes Self-Management in Pregnant Women With Gestational Diabetes

NCT06148688 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-11-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of digital storytelling intervention on diabetes self-management in women with gestational diabetes. It is a quasi-experimental study with a pretest-posttest control group.

The main hypotheses of the study are:

Digital storytelling has an impact on women with gestational diabetes' perception of diabetes self-management.

Digital storytelling has an impact on the diabetes self-efficacy levels of women with gestational diabetes.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy
  • Diabetes Self Management

Interventions

OTHER

Digital Story

Digital storytelling; It is used in education and training, business marketing, non-profit organizations such as libraries, community centers and museums, and health sciences education. Digital storytelling in health sciences can be a tool for patients and health science professionals to share their experiences, cope with diseases, and add a human element to health problems. In the study, digital stories were created to increase the self-management of pregnant women with gestational diabetes. In creating a digital story; Qualitative studies involving the self-management experiences of women with gestational diabetes have been examined in the literature. Using the results of the studies, scenarios were created that included factors that facilitate and complicate diabetes self-management. The created scenarios were used in the digital storytelling initiative. A total of four long and four short digital story videos were prepared.

Sponsors & Collaborators

  • Ege University

    collaborator OTHER

  • Izmir Katip Celebi University

    lead OTHER

Principal Investigators

  • Gülşen Işık · Izmir Katip Celebi University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148688 on ClinicalTrials.gov